Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China · Delayed Price · Currency is CNY 9.75
-0.42 (-4.13%)
Jun 4, 2026, 3:00 PM CST
Shenzhen YHLO Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 31.14 | 23.34 | 301.53 | 355.01 | 1,012 | 204.75 |
Depreciation & Amortization | 285.73 | 285.73 | 247.21 | 197 | 144.73 | 99.32 |
Other Amortization | 12.35 | 12.35 | 9.01 | 13.57 | 29.91 | 5.21 |
Loss (Gain) From Sale of Assets | 0.34 | 0.34 | -1.82 | -2.79 | 3.39 | 0.2 |
Asset Writedown & Restructuring Costs | 3.74 | 3.74 | 9.71 | 9.8 | 10.33 | - |
Loss (Gain) From Sale of Investments | 67.34 | 67.34 | 31.52 | -85.35 | -59.84 | 2.82 |
Provision & Write-off of Bad Debts | 8.5 | 8.5 | 10.58 | 7.84 | 11.07 | 2.6 |
Other Operating Activities | 164.91 | 88.46 | -0.91 | -11.8 | 114.83 | 26.53 |
Change in Accounts Receivable | -79.39 | -79.39 | -130.55 | 12.93 | -190.33 | -54.96 |
Change in Inventory | 90.09 | 90.09 | 5.8 | -101.71 | -340.52 | -67.37 |
Change in Accounts Payable | -86.71 | -86.71 | 33.01 | -477.25 | 843.34 | 43.78 |
Change in Other Net Operating Assets | 15.05 | 15.05 | 15.64 | 13.49 | 21.41 | - |
Operating Cash Flow | 506.11 | 421.85 | 529.9 | -73.19 | 1,583 | 259.62 |
Operating Cash Flow Growth | 8.63% | -20.39% | - | - | 509.80% | -7.99% |
Capital Expenditures | -411.51 | -359.24 | -593.31 | -662.71 | -565.37 | -372.66 |
Sale of Property, Plant & Equipment | 0.07 | 0.06 | 0.02 | 0.06 | 0.03 | - |
Cash Acquisitions | - | - | -0.03 | - | -6.3 | - |
Divestitures | 0.73 | 0.73 | - | -21.57 | - | - |
Investment in Securities | 42.16 | -0.96 | -160.71 | 22.25 | -280.48 | -91.68 |
Other Investing Activities | 32.51 | 24.85 | 5.5 | 27.1 | -17.71 | 3.27 |
Investing Cash Flow | -336.06 | -334.55 | -748.52 | -634.88 | -869.83 | -461.08 |
Long-Term Debt Issued | - | 868.57 | 572.41 | 530.09 | 683.38 | 367.96 |
Long-Term Debt Repaid | - | -872.75 | -232.6 | -287.69 | -449.87 | -454.13 |
Net Debt Issued (Repaid) | 75.18 | -4.18 | 339.81 | 242.4 | 233.51 | -86.17 |
Issuance of Common Stock | 8.66 | 10.32 | 21.11 | 17.26 | - | 561.76 |
Common Dividends Paid | -142.47 | -141.58 | -169.03 | -282.53 | -169 | -10.9 |
Other Financing Activities | -13.27 | -15.28 | -11.17 | 3.61 | -51.03 | -17.15 |
Financing Cash Flow | -71.9 | -150.72 | 180.71 | -19.26 | 13.47 | 447.55 |
Foreign Exchange Rate Adjustments | 0.7 | -0.92 | -6 | 3.98 | 10.25 | -1.41 |
Net Cash Flow | 98.85 | -64.35 | -43.92 | -723.34 | 737.05 | 244.68 |
Free Cash Flow | 94.59 | 62.61 | -63.41 | -735.9 | 1,018 | -113.04 |
Free Cash Flow Margin | 5.28% | 3.46% | -3.15% | -35.84% | 25.57% | -9.60% |
Free Cash Flow Per Share | 0.16 | 0.11 | -0.11 | -1.28 | 1.79 | -0.21 |
Cash Income Tax Paid | 91.87 | 118.12 | 107.31 | 145.81 | 234.29 | 80.03 |
Levered Free Cash Flow | -55.85 | -56.76 | -202.96 | -943.74 | 855.65 | -122.11 |
Unlevered Free Cash Flow | -41.81 | -42.46 | -195.35 | -939.83 | 860.91 | -115.1 |
Change in Working Capital | -67.95 | -67.95 | -76.95 | -556.47 | 316.61 | -81.8 |